Jazz Pharmaceuticals PLC (JAZZ)
127.05
+1.95
(+1.56%)
USD |
NASDAQ |
Nov 22, 13:27
Jazz Pharmaceuticals Total Liabilities (Quarterly): 8.085B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 8.085B |
June 30, 2024 | 7.599B |
March 31, 2024 | 7.631B |
December 31, 2023 | 7.656B |
September 30, 2023 | 7.715B |
June 30, 2023 | 7.735B |
March 31, 2023 | 7.712B |
December 31, 2022 | 7.750B |
September 30, 2022 | 7.639B |
June 30, 2022 | 7.999B |
March 31, 2022 | 8.160B |
December 31, 2021 | 8.333B |
September 30, 2021 | 8.540B |
June 30, 2021 | 9.082B |
March 31, 2021 | 2.959B |
December 31, 2020 | 2.876B |
September 30, 2020 | 2.915B |
June 30, 2020 | 2.925B |
March 31, 2020 | 2.407B |
December 31, 2019 | 2.428B |
September 30, 2019 | 2.473B |
June 30, 2019 | 2.505B |
March 31, 2019 | 2.550B |
December 31, 2018 | 2.446B |
September 30, 2018 | 2.458B |
Date | Value |
---|---|
June 30, 2018 | 2.479B |
March 31, 2018 | 2.501B |
December 31, 2017 | 2.411B |
September 30, 2017 | 2.530B |
June 30, 2017 | 2.603B |
March 31, 2017 | 2.832B |
December 31, 2016 | 2.923B |
September 30, 2016 | 3.215B |
June 30, 2016 | 1.756B |
March 31, 2016 | 1.928B |
December 31, 2015 | 1.734B |
September 30, 2015 | 1.901B |
June 30, 2015 | 1.946B |
March 31, 2015 | 1.932B |
December 31, 2014 | 1.968B |
September 30, 2014 | 2.007B |
June 30, 2014 | 1.876B |
March 31, 2014 | 1.930B |
December 31, 2013 | 942.69M |
September 30, 2013 | 941.80M |
June 30, 2013 | 918.43M |
March 31, 2013 | 847.79M |
December 31, 2012 | 845.20M |
September 30, 2012 | 840.61M |
June 30, 2012 | 866.48M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.407B
Minimum
Mar 2020
9.082B
Maximum
Jun 2021
6.407B
Average
7.684B
Median
Total Liabilities (Quarterly) Benchmarks
Avadel Pharmaceuticals PLC | 83.59M |
Alkermes PLC | 863.18M |
Medtronic PLC | 41.33B |
Perrigo Co PLC | 6.637B |
Iterum Therapeutics PLC | 25.78M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 12.26B |
Shareholders Equity (Quarterly) | 4.171B |
Debt to Equity Ratio | 1.465 |
Current Ratio | 4.263 |
Net Debt Paydown Yield | -1.17% |